| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 52 |
| 1 | EVEROLIMUS | 36 |
| 2 | CABOZANTINIB | 30 |
| 3 | NIVOLUMAB | 25 |
| 4 | CARBOPLATIN | 24 |
| 5 | PAZOPANIB HYDROCHLORIDE | 23 |
| 6 | FUROSEMIDE | 20 |
| 7 | ASPIRIN | 19 |
| 8 | ASPIRIN 325 MG | 19 |
| 9 | ASPIRIN 81 MG | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VARDENAFIL | 3 | 0.0050 |
| 1 | SODIUM HYPOCHLORITE | 1 | 0.0038 |
| 2 | VADADUSTAT | 1 | 0.0033 |
| 3 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 4 | METHAZOLAMIDE | 1 | 0.0029 |
| 5 | INTERLEUKIN-10 | 1 | 0.0028 |
| 6 | NALDEMEDINE | 4 | 0.0024 |
| 7 | INOTUZUMAB OZOGAMICIN | 7 | 0.0023 |
| 8 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0021 |
| 9 | ROLAPITANT | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 81 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 |
| 2 | Corticosteroid [EPC] | 37 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 37 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 5 | Platinum-based Drug [EPC] | 33 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 7 | Proton Pump Inhibitor [EPC] | 25 |
| 8 | Alkylating Drug [EPC] | 23 |
| 9 | Benzodiazepine [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Somatostatin Analog [EPC] | 5 | 0.0007 |
| 3 | Asparagine-specific Enzyme [EPC] | 8 | 0.0006 |
| 4 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 | 0.0004 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 8 | 0.0004 |